JP2010511596A5 - - Google Patents

Download PDF

Info

Publication number
JP2010511596A5
JP2010511596A5 JP2009524032A JP2009524032A JP2010511596A5 JP 2010511596 A5 JP2010511596 A5 JP 2010511596A5 JP 2009524032 A JP2009524032 A JP 2009524032A JP 2009524032 A JP2009524032 A JP 2009524032A JP 2010511596 A5 JP2010511596 A5 JP 2010511596A5
Authority
JP
Japan
Prior art keywords
hyaluronic acid
acid derivative
solution
crosslinked hyaluronic
injection solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009524032A
Other languages
English (en)
Japanese (ja)
Other versions
JP5291621B2 (ja
JP2010511596A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2007/073987 external-priority patent/WO2008069348A1/en
Publication of JP2010511596A publication Critical patent/JP2010511596A/ja
Publication of JP2010511596A5 publication Critical patent/JP2010511596A5/ja
Application granted granted Critical
Publication of JP5291621B2 publication Critical patent/JP5291621B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009524032A 2006-12-06 2007-12-06 関節疾患に対する持続的治療効果を有する薬剤 Active JP5291621B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86879806P 2006-12-06 2006-12-06
US60/868,798 2006-12-06
PCT/JP2007/073987 WO2008069348A1 (en) 2006-12-06 2007-12-06 Pharmaceutical agent having long-lasting effect of treating arthritic disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013120712A Division JP5600192B2 (ja) 2006-12-06 2013-06-07 関節疾患に対する持続的治療効果を有する薬剤

Publications (3)

Publication Number Publication Date
JP2010511596A JP2010511596A (ja) 2010-04-15
JP2010511596A5 true JP2010511596A5 (OSRAM) 2013-05-23
JP5291621B2 JP5291621B2 (ja) 2013-09-18

Family

ID=39203191

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009524032A Active JP5291621B2 (ja) 2006-12-06 2007-12-06 関節疾患に対する持続的治療効果を有する薬剤
JP2013120712A Active JP5600192B2 (ja) 2006-12-06 2013-06-07 関節疾患に対する持続的治療効果を有する薬剤
JP2014165127A Active JP5889976B2 (ja) 2006-12-06 2014-08-14 関節疾患に対する持続的治療効果を有する薬剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013120712A Active JP5600192B2 (ja) 2006-12-06 2013-06-07 関節疾患に対する持続的治療効果を有する薬剤
JP2014165127A Active JP5889976B2 (ja) 2006-12-06 2014-08-14 関節疾患に対する持続的治療効果を有する薬剤

Country Status (9)

Country Link
US (3) US8889652B2 (OSRAM)
EP (3) EP2386306A1 (OSRAM)
JP (3) JP5291621B2 (OSRAM)
KR (1) KR101460815B1 (OSRAM)
CN (2) CN101573123B (OSRAM)
AU (1) AU2007328871B2 (OSRAM)
CA (1) CA2672002C (OSRAM)
TW (2) TWI528964B (OSRAM)
WO (1) WO2008069348A1 (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008069348A1 (en) 2006-12-06 2008-06-12 Seikagaku Corporation Pharmaceutical agent having long-lasting effect of treating arthritic disorders
JO3008B1 (ar) 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم
ITTO20110428A1 (it) * 2011-05-13 2012-11-14 Rottapharm Spa Esteri dell'acido ialuronico, loro preparazione ed uso in dermatologia
JO3564B1 (ar) 2013-03-08 2020-07-05 Novartis Ag ببتيدات وتركيبات لعلاج ضرر المفاصل
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
EP3020733A4 (en) 2013-07-08 2017-03-15 Denka Company Limited Core-shell crosslinked hyaluronic acid gel particles, production method for same, and medical material
US20150133561A1 (en) * 2013-11-12 2015-05-14 Vizuri Health Sciences Llc Aqueous based capsaicinoid formulations and methods of manufacture and use
KR20160002256A (ko) * 2014-06-30 2016-01-07 (주)메디톡스 가교된 히알루론난을 유효성분으로 포함하는 골관절염 치료용 약제학적 조성물 및 그를 이용한 골관절염 치료 방법
KR102357341B1 (ko) * 2014-11-06 2022-02-03 주식회사 엘지생활건강 숙지황 추출물을 포함하는 히알루론산 생성 촉진용 조성물과 이의 이용
KR101521411B1 (ko) * 2015-02-05 2015-05-19 박재우 뼈 및 연골을 포함한 관절질환 치료용 조성물 및 이의 제조방법
ES2914684T3 (es) * 2015-08-19 2022-06-15 Univ Iowa Res Found Terapia preventiva para la artrosis postraumática
KR101637883B1 (ko) * 2015-09-30 2016-07-21 선바이오(주) 폴리에틸렌글리콜 수화젤 주사제
KR101895950B1 (ko) * 2015-12-18 2018-09-06 (주)한국비엠아이 골관절염 치료를 위한 친수화된 설파살라진 및 히알루론산을 포함하는 조성물 및 이의제조방법
EP3597199A4 (en) 2017-03-14 2021-01-20 Seikagaku Corporation JOINT DISEASE TREATMENT COMPOSITION AND KIT WITH IT
TW202027794A (zh) 2018-10-03 2020-08-01 瑞士商諾華公司 血管生成素樣3多肽之持續遞送
FR3105729B1 (fr) * 2019-12-31 2023-07-21 Mrs Biotech Composition pour la gestion du poids d’un sujet
CN115444840B (zh) * 2022-09-15 2023-08-25 四川大学 一种前药、两性离子水凝胶及其制备方法、应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61210034A (ja) 1985-03-15 1986-09-18 Seikagaku Kogyo Co Ltd 関節症治療剤
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
JPH0574571A (ja) 1990-12-25 1993-03-26 Ricoh Co Ltd 電界発光素子
JP2855307B2 (ja) * 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
US6025444A (en) 1994-11-17 2000-02-15 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Cinnamic acid derivative
JP3343181B2 (ja) * 1995-09-20 2002-11-11 生化学工業株式会社 桂皮酸誘導体
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
JP3955107B2 (ja) * 1995-05-01 2007-08-08 生化学工業株式会社 架橋多糖の製造法
HU224697B1 (en) * 1995-11-15 2006-01-30 Seikagaku Kogyo Co Ltd Photocured cross-linked-hyaluronic acid gel and method of preparation thereof
DE69822285T2 (de) 1998-02-27 2005-01-27 Stichting Hyppomedics Verfahren zur Herstellung von vernetzter Hyaluronsäure
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
WO2001057093A1 (en) * 2000-02-03 2001-08-09 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, process for producing the same, and medical material containing the same
JP4172176B2 (ja) * 2000-12-19 2008-10-29 生化学工業株式会社 光反応性ヒアルロン酸およびその製造方法ならびに光架橋ヒアルロン酸および医用材料
DE60117502T2 (de) 2000-12-19 2006-08-24 Seikagaku Corp. Photohärtbare Derivate von Hyaluronsäure, Verfahren zu deren Herstellung, vernetztes und photogehärtetes Derivat der Hyaluronsäure und diese enthaltendes medizinisches Material
JP4990446B2 (ja) 2001-05-28 2012-08-01 電気化学工業株式会社 関節症治療用注入剤
JP4958368B2 (ja) 2002-02-28 2012-06-20 電気化学工業株式会社 架橋ヒアルロン酸
AU2005283282B2 (en) 2004-09-15 2011-05-19 Seikagaku Corporation Photoreactive polysaccharide, photocrosslinked polysaccharide products, the method of making them and medical materials therefrom
CA2590159C (en) 2004-12-30 2011-07-12 Genzyme Corporation Regimens for intra-articular viscosupplementation
RU2429018C2 (ru) 2005-07-06 2011-09-20 Сейкагаку Корпорейшн Гель, полученный из фотосшитой гиалуроновой кислоты с введенным лекарственным средством
ES2616295T3 (es) 2005-10-12 2017-06-12 Seikagaku Corporation Agente para aplicar a mucosa y procedimiento para la producción del mismo
WO2008069348A1 (en) * 2006-12-06 2008-06-12 Seikagaku Corporation Pharmaceutical agent having long-lasting effect of treating arthritic disorders
JO3008B1 (ar) 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم

Similar Documents

Publication Publication Date Title
JP2010511596A5 (OSRAM)
JP2016517434A5 (OSRAM)
EP2292235A3 (de) Methotrexat-Lösungen
AU2011322255A1 (en) Inflammatory disease
JP6417488B2 (ja) 疼痛抑制用医薬組成物
RU2008138381A (ru) Режимы дозирования адреналина
JP2016526039A5 (OSRAM)
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
RU2016139373A (ru) Растворы бупренорфина с замедленным высвобождением
JP2017538705A5 (OSRAM)
CN104323987B (zh) 一种乙酰甲喹注射液及其制备方法
KR20160094952A (ko) 수계 캡사이시노이드 제형 및 제조방법 및 용도
HRP20240812T1 (hr) Oblici doziranja i terapijska primjena l-4-klorokinurenina
BRPI0815280A2 (pt) medicamento que compreende uma formulação líquida aquosa de g-csf, receptáculo para a administração de medicamentos líquidos, seringa ou ampola, kit para a administração parenteral de g-csf
TWI605821B (zh) 南洋山蘇水萃物的用途
CN105597079A (zh) 用于治疗银屑病的药物
CN108697758B (zh) 用于有效控制急性和/或慢性疼痛的药物及其施用方法
CN101954084B (zh) 一种治疗畜禽混合感染的药物组合物及其制备方法
CN105726557B (zh) 异长春花苷内酰胺在制备治疗肠应激综合征的药物中的应用
CN100537593C (zh) 甘草酸复盐及其制剂
CN102274164B (zh) 帕潘立酮及帕潘立酮衍生物的注射用缓释凝胶剂
RU2008126108A (ru) Фармацевтическая композиция для лечения остеоартрита, содержащая клодроновую кислоту и гиалуроновую кислоту
ES2376023T3 (es) Utilización de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-piridin-4-il)-5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales.
CA2994748C (en) Pharmaceutical composition comprising sumatripan for treating migraine